Pallas Capital Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$880K Buy
7,441
+2,335
+46% +$270K 0.03% 394
2026
Q1
$610K Buy
5,106
+1,077
+27% +$141K 0.02% 450
2025
Q4
$549K Sell
4,029
-38
-0.9% -$5.47K 0.02% 507
2025
Q3
$600K Buy
4,067
+41
+1% +$5.69K 0.02% 471
2025
Q2
$521K Buy
4,026
+71
+2% +$8.6K 0.02% 491
2025
Q1
$473K Buy
3,955
+8
+0.2% +$991 0.02% 483
2024
Q4
$458K Sell
3,947
-64
-2% -$8.09K 0.02% 378
2024
Q3
$524K Buy
4,011
+33
+0.8% +$4.42K 0.02% 344
2024
Q2
$549K Buy
3,978
+58
+1% +$7.89K 0.02% 301
2024
Q1
$507K Sell
3,920
-11
-0.3% -$1.33K 0.02% 278
2023
Q4
$449K Buy
3,931
+11
+0.3% +$1.1K 0.02% 278
2023
Q3
$350K Buy
+3,920
New +$404K 0.02% 274

Other funds holding XYL

Pallas Capital Advisors's XYL Position: Q2 2026 in Review

Pallas Capital Advisors increased its Xylem (XYL) stake by 46% in Q2 2026, buying an estimated $270K and bringing the position to 7,441 shares worth $880K. The position accounts for 0.03% of the portfolio, ranked #394.

Pallas Capital Advisors first reported a position in XYL in Q3 2023 and has held it in 12 quarters since. 1,103 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Pallas Capital Advisors held 7,441 shares of Xylem worth $880K as of Q2 2026.
  • Pallas Capital Advisors bought 2,335 Xylem shares in Q2 2026, an estimated $270K.
  • Xylem made up 0.03% of Pallas Capital Advisors's portfolio in Q2 2026, its #394 holding.
  • Pallas Capital Advisors first reported a position in Xylem in Q3 2023 and has held it in 12 quarters since.
  • 1,103 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.